Clinical Trial Update: Treatment of Uremic Pruritus With PA101B [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating PA101B for treating uremic pruritus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremic Pruritus

Drugs mentioned

• PA101B

Snippet

Sponsor: Patara Pharma | Conditions: Uremic Pruritus | Phase 2 | Status: COMPLETED